Desensitization to hydroxychloroquine: 4 Cases

Journal of Rheumatology

Volumn 38, Issue 10, 2011, Pages 2267-

  Caramaschi, Paola ^a   Barbazza, Roberto ^a   Tinazzi, Ilaria ^a   Biasi, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

CLINICAL PROTOCOL; DESENSITIZATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RECHALLENGE; DRUG SAFETY; ERYTHRODERMA; EXFOLIATIVE ERYTHRODERMA; HUMAN; LETTER; MACULOPAPULAR RASH; PATIENT MONITORING; PRICK TEST; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ANTIRHEUMATIC AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYDROXYCHLOROQUINE;

EID: 80053557016     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110345     Document Type: Letter

References (4)

1. Mates M, Zevin S, Breuer GS, Navon P, Nesher G. Desensitization to hydroxychloroquine - experience of 4 patients. J Rheumatol 2006;33:814-6.
2. Sontheimer RD. Desensitization to hydroxychloroquine: alternative interpretations [editorial]. J Rheumatol 2007;34:253-5.
3. Díaz Donado C, Maquiera Díez E. Successful desensitization for hydroxychloroquine anaphylaxis. J Rheumatol 2010;37:1975-7.
4. Fam AG, Dunne SM, Iazzetta J, Paton TW. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 2001;44:231-8. (Pubitemid 32113139)